and Research Directions: A Scientific Statement From the American Heart Association Prevention, Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who

[1]  S. Lipshultz,et al.  Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity , 2014, Toxicologic pathology.

[2]  S. Lipshultz,et al.  Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.

[3]  S. Lipshultz,et al.  Cardiotoxicity in childhood cancer survivors: A problem with long‐term consequences in need of early detection and prevention , 2013, Pediatric blood & cancer.

[4]  S. Lipshultz,et al.  An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies , 2013, Expert opinion on pharmacotherapy.

[5]  S. Lipsitz,et al.  Dietary Quality, Caloric Intake, and Adiposity of Childhood Cancer Survivors and Their Siblings: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study , 2013, Nutrition and cancer.

[6]  H. Caron,et al.  A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group , 2013, Pediatric blood & cancer.

[7]  Angela M. Miller,et al.  Exercise capacity in long‐term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study , 2013, Pediatric blood & cancer.

[8]  R. Steiner.  Increasing exercise in long‐term survivors of pediatric cancer and their siblings: Should treatment be a family affair? , 2013, Pediatric blood & cancer.

[9]  S. Lipsitz,et al.  Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study , 2013, Pediatric Cardiology.

[10]  J. Wilkinson,et al.  Screening for long-term cardiac status during cancer treatment. , 2012, Circulation. Cardiovascular imaging.

[11]  S. Lipshultz,et al.  Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. , 2012, Future cardiology.

[12]  J. Wilkinson,et al.  Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? , 2012, Pediatric endocrinology reviews : PER.

[13]  M. Aznar,et al.  Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. , 2012, International journal of radiation oncology, biology, physics.

[14]  S. Lipshultz,et al.  Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Sallan,et al.  Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia , 2012, Journal of pediatric hematology/oncology.

[16]  Olivier Laurent,et al.  Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks , 2012, Environmental health perspectives.

[17]  K. Krull,et al.  Perceived positive impact of cancer among long‐term survivors of childhood cancer: a report from the childhood cancer survivor study , 2012, Psycho-oncology.

[18]  S. Lipshultz,et al.  Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer , 2012 .

[19]  L. Tapsell,et al.  Dietary intake after treatment in child cancer survivors , 2012, Pediatric blood & cancer.

[20]  C. Koning,et al.  High risk of symptomatic cardiac events in childhood cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Steinberger,et al.  Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation , 2012 .

[22]  S. Lipsitz,et al.  Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Lipsitz,et al.  Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Steinberger,et al.  Cardiovascular risk and insulin resistance in childhood cancer survivors. , 2012, The Journal of pediatrics.

[25]  C. Pui,et al.  Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies , 2012, Pediatric blood & cancer.

[26]  G. Armstrong,et al.  Physical activity among adult survivors of childhood lower-extremity sarcoma , 2012, Journal of Cancer Survivorship.

[27]  S. Lipsitz,et al.  Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. , 2012, American heart journal.

[28]  A. Varan,et al.  Tissue doppler evaluation of systolic and diastolic cardiac functions in long‐term survivors of Hodgkin lymphoma , 2012, Pediatric blood & cancer.

[29]  R. Ross,et al.  Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia , 2012, Pediatric blood & cancer.

[30]  C. Sklar,et al.  Therapy for pediatric brain tumors and the risk of growth hormone deficiency. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  T. Merchant,et al.  Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Kodama,et al.  Radiation Dose Associated with Renal Failure Mortality: A Potential Pathway to Partially Explain Increased Cardiovascular Disease Mortality Observed after Whole-Body Irradiation , 2011, Radiation research.

[33]  Jiaquan Xu,et al.  Deaths: final data for 2008. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[34]  S. Meikle,et al.  Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[35]  W. Demark-Wahnefried,et al.  Health behaviors and weight status of childhood cancer survivors and their parents: similarities and opportunities for joint interventions. , 2011, Journal of the American Dietetic Association.

[36]  J. Ornato,et al.  Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. , 2011, JAMA.

[37]  M. Pulsipher,et al.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[38]  K. Ness,et al.  Exercise Interventions in Children with Cancer: A Review , 2011, International journal of pediatrics.

[39]  B. Rosenzweig,et al.  A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat , 2011, Toxicologic pathology.

[40]  M. Heymans,et al.  Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults. , 2011, The Journal of clinical endocrinology and metabolism.

[41]  B. Rensing,et al.  Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. , 2011, Cancer treatment reviews.

[42]  G. Armstrong,et al.  Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  T. D. de Backer,et al.  CARDIOVASCULAR TOXICITY OF CANCER TREATMENT , 2011, Acta clinica Belgica.

[44]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[45]  S. Baruchel,et al.  Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study , 2011, Clinical Cancer Research.

[46]  H. Dickinson,et al.  Cardioprotective interventions for cancer patients receiving anthracyclines. , 2011, The Cochrane database of systematic reviews.

[47]  J. Jassem,et al.  Cardiovascular effects of systemic cancer treatment. , 2011, Cancer treatment reviews.

[48]  D. Lefkopoulos,et al.  Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. , 2011, International journal of radiation oncology, biology, physics.

[49]  D. Neuberg,et al.  The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. , 2011, European journal of cancer.

[50]  J. Fulbright.  Review of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy , 2011, Cardiology research and practice.

[51]  Randolph P. Martin,et al.  Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. , 2011, The American journal of cardiology.

[52]  J. Grill,et al.  Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. , 2011, Brain : a journal of neurology.

[53]  S. Bakhshi,et al.  5-Fluorouracil-induced acute dilated cardiomyopathy in a pediatric patient. , 2011, Journal of pediatric hematology/oncology.

[54]  P. Auquier,et al.  Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia , 2011 .

[55]  Benjamin Willis,et al.  Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. , 2011, Journal of the American College of Cardiology.

[56]  Jens-Uwe Voigt,et al.  Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. , 2011, International journal of radiation oncology, biology, physics.

[57]  N. Weissman,et al.  A suggested roadmap for cardiovascular ultrasound research for the future. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[58]  W. Landier,et al.  The perceived impact of cancer on quality of life for post-treatment survivors of childhood cancer , 2011, Quality of Life Research.

[59]  M. Beer,et al.  Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease. , 2011, International journal of radiation oncology, biology, physics.

[60]  T. Shimizu,et al.  High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT , 2011, Bone Marrow Transplantation.

[61]  D. Friedman,et al.  Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia , 2011, Pediatric blood & cancer.

[62]  S. Lipshultz,et al.  Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines , 2011, Cardiology research and practice.

[63]  S. Lipshultz,et al.  Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer , 2011, Pediatric Cardiology.

[64]  G. Pongiglione,et al.  Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors , 2011, Pediatric blood & cancer.

[65]  R. Pötter,et al.  Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow‐up project of the German–Austrian DAL‐HD studies , 2010, Pediatric blood & cancer.

[66]  D. Friedman,et al.  Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[67]  P. McAuley,et al.  Cardiorespiratory fitness, adiposity, and all-cause mortality in women. , 2010, Medicine and science in sports and exercise.

[68]  Pamela K Woodard,et al.  Accuracy and reproducibility of strain by speckle tracking in pediatric subjects with normal heart and single ventricular physiology: a two-dimensional speckle-tracking echocardiography and magnetic resonance imaging correlative study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[69]  J. Kastelein,et al.  Increased prevalence of risk factors for cardiovascular disease in long‐term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy , 2010, Pediatric blood & cancer.

[70]  S. Lipsitz,et al.  Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. , 2010, The Lancet. Oncology.

[71]  A. Allegra,et al.  Cardiac Involvement in Patients With Hematologic Malignancies , 2010, Journal of Investigative Medicine.

[72]  P. Anderson,et al.  Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic? , 2010, Current oncology reports.

[73]  Giuseppe Curigliano,et al.  Cardiac toxicity from systemic cancer therapy: a comprehensive review. , 2010, Progress in cardiovascular diseases.

[74]  D. Hsu,et al.  BNP Levels Predict Outcome in Pediatric Heart Failure Patients: Post Hoc Analysis of the Pediatric Carvedilol Trial , 2010, Circulation. Heart failure.

[75]  J. Björk,et al.  Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. , 2010, The Journal of clinical endocrinology and metabolism.

[76]  N. Artinian,et al.  Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. , 2010, Circulation.

[77]  M. Hauptmann,et al.  Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. , 2010, Archives of internal medicine.

[78]  S. Lipsitz,et al.  Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[79]  J. Neglia,et al.  Health and risk behaviors in survivors of childhood acute myeloid leukemia: A report from the Children's Oncology Group , 2010, Pediatric blood & cancer.

[80]  A. Craft,et al.  Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose , 2010, Pediatric blood & cancer.

[81]  S. Pakakasama,et al.  Impaired Glucose Tolerance and Insulin Resistance in Survivors of Childhood Acute Lymphoblastic Leukemia: Prevalence and Risk Factors , 2010, Journal of pediatric hematology/oncology.

[82]  B. Rosenzweig,et al.  Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats , 2010, Cancer Chemotherapy and Pharmacology.

[83]  F. Pınarlı,et al.  Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[84]  L. Sharp,et al.  Diet and Physical Activity in Childhood Cancer Survivors: A Review of the Literature , 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[85]  K. Ness,et al.  Physical performance limitations among adult survivors of childhood brain tumors , 2010, Cancer.

[86]  P. Lähteenmäki,et al.  Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia , 2010, Journal of cancer survivorship : research and practice.

[87]  S. Uijtdehaage,et al.  Prevalence and Predictors of Posttraumatic Stress Disorder in Adult Survivors of Childhood Cancer , 2010, Pediatrics.

[88]  K. Wolin,et al.  Exercise in adult and pediatric hematological cancer survivors: an intervention review , 2010, Leukemia.

[89]  B. Storer,et al.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[90]  S. Lipshultz,et al.  Cardiotoxicity after childhood cancer: beginning with the end in mind. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  Lingling Zhu,et al.  Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. , 2010, Blood.

[92]  H. Caron,et al.  Hypertension in long-term survivors of childhood cancer: a nested case-control study. , 2010, European journal of cancer.

[93]  A. Varan,et al.  Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  L. Diller,et al.  Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  Mark A Sussman,et al.  Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice , 2010, Circulation.

[96]  S. De Flora,et al.  Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention , 2010, Journal of the National Cancer Institute.

[97]  K. Ness,et al.  Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer—A Report from the Childhood Cancer Survivor Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[98]  M. Hudson,et al.  Survivorship: childhood cancer survivors. , 2009, Primary care.

[99]  K. Yeom,et al.  Cerebrovascular disease in childhood cancer survivors , 2009, Neurology.

[100]  A. Dipchand,et al.  Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[101]  L. Cozzi,et al.  Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. , 2009, International journal of radiation oncology, biology, physics.

[102]  A. Craft,et al.  Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. , 2009, European journal of cancer.

[103]  R. Pieters,et al.  Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[104]  J. Svensson,et al.  Safety aspects of GH replacement. , 2009, European journal of endocrinology.

[105]  H. Azim,et al.  Trastuzumab versus lapatinib: the cardiac side of the story. , 2009, Cancer treatment reviews.

[106]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[107]  L. Robinson,et al.  Anti-Smoking Communication to Preadolescents With and Without a Cancer Diagnosis: Parents and Health Care Providers as Important Communicators , 2009, Children's health care : journal of the Association for the Care of Children's Health.

[108]  C. Tu,et al.  Trastuzumab (Herceptin)-associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review. , 2009, The American journal of emergency medicine.

[109]  D. Mulrooney,et al.  Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[110]  C. Sklar,et al.  Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study , 2009, Bone Marrow Transplantation.

[111]  L. Saccá,et al.  Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. , 2009, The Journal of clinical endocrinology and metabolism.

[112]  Jong Hun Park,et al.  Cardiac Functional Evaluation Using Vector Velocity Imaging After Chemotherapy Including Anthracyclines in Children With Cancer , 2009, Korean circulation journal.

[113]  L. Robison,et al.  Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. , 2009, Archives of internal medicine.

[114]  T. Marwick,et al.  Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. , 2009, American heart journal.

[115]  R. Ross,et al.  Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[116]  H. Kal,et al.  Induction of severe cataract and late renal dysfunction following total body irradiation: dose-effect relationships. , 2009, Anticancer research.

[117]  A. D. Van den Abbeele,et al.  Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib , 2009, Pediatric blood & cancer.

[118]  G. Rosner,et al.  Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study , 2009, Cancer Chemotherapy and Pharmacology.

[119]  E. Yeh,et al.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.

[120]  Yasuo Ohashi,et al.  Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. , 2009, JAMA.

[121]  P. Nathan,et al.  Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[122]  G. Armstrong,et al.  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  Marilyn Stovall,et al.  Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  M. Piccart-Gebhart,et al.  Cardiac toxicity with anti-HER-2 therapies-what have we learned so far? , 2009, Targeted Oncology.

[125]  S. Baruchel,et al.  In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model. , 2009, Neoplasia.

[126]  J. Dixon,et al.  Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[127]  G. Armstrong,et al.  Predictors of inactive lifestyle among adult survivors of childhood cancer , 2009, Cancer.

[128]  E. Feuer,et al.  Long-Term Survivors of Childhood Cancers in the United States , 2009, Cancer Epidemiology Biomarkers & Prevention.

[129]  D. Jassal,et al.  Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[130]  E. D. de Vries,et al.  Cardiovascular toxicity caused by cancer treatment: strategies for early detection. , 2009, The Lancet. Oncology.

[131]  K. Muroya,et al.  Unfavorable lipoprotein profile in childhood cancer survivors with suprasellar brain tumors—a high Apo B level and increased small dense LDL-cholesterol , 2009, Child's Nervous System.

[132]  B. Popkin,et al.  Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, , 2009, Circulation.

[133]  A. Heusch,et al.  Present Risk of Anthracycline or Radiation-induced Cardiac Sequelae Following Therapy of Malignancies in Children and Adolescents , 2009, Klinische Padiatrie.

[134]  D. Green,et al.  Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group , 2008, Pediatric blood & cancer.

[135]  C. Zielinski,et al.  Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[136]  K. Ness,et al.  Poor Adherence to Dietary Guidelines Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia , 2008, Journal of pediatric hematology/oncology.

[137]  A. Garden,et al.  Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  A. Ludomirsky,et al.  Maturational and growth-related changes in left ventricular longitudinal strain and strain rate measured by two-dimensional speckle tracking echocardiography in healthy pediatric population. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[139]  L. Robison,et al.  Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[140]  Wendy Leisenring,et al.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. , 2008, Journal of the National Cancer Institute.

[141]  T. Salmi,et al.  Long‐term follow‐up of renal function after high‐dose methotrexate treatment in children , 2008, Pediatric blood & cancer.

[142]  M. D. De Bruin,et al.  Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. , 2008, Journal of the National Cancer Institute.

[143]  M. Barrera,et al.  Smoking and binge drinking among Canadian survivors of childhood and adolescent cancers: A comparative, population‐based study , 2008, Pediatric blood & cancer.

[144]  Narine Sarvazyan,et al.  Anthracycline cardiotoxicity: from bench to bedside. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[145]  R. Steingart,et al.  Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. , 2008, AJR. American journal of roentgenology.

[146]  R. Goldsby,et al.  Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. , 2008, Addiction.

[147]  S. Keir,et al.  Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program , 2008, Pediatric blood & cancer.

[148]  M. Relling,et al.  Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancer , 2008, Cancer.

[149]  M. Halushka,et al.  Heart failure associated with sunitinib malate , 2008, Cancer.

[150]  E. Perez,et al.  Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials. , 2008, Mayo Clinic proceedings.

[151]  S. Palmer,et al.  Cardiovascular risk in long‐term survivors of testicular cancer , 2008, Cancer.

[152]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[153]  A. Rogol,et al.  Growth hormone deficiency in children , 2008, Pituitary.

[154]  B. Drew,et al.  Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. , 2008, Circulation.

[155]  D. Jacobs,et al.  Measurement of Insulin Sensitivity in Children , 2008, Diabetes Care.

[156]  S. Lipshultz,et al.  Cardiometabolic disease in human immunodeficiency virus-infected children. , 2008, Journal of the cardiometabolic syndrome.

[157]  D. Neuberg,et al.  Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[158]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[159]  E. Ford,et al.  Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. , 2008, The Journal of pediatrics.

[160]  J. Steinberger,et al.  Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group , 2008, Pediatrics.

[161]  D. Jassal,et al.  Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[162]  P. Adamson,et al.  Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. , 2008, Blood.

[163]  J. Ross,et al.  Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.

[164]  F. Stewart,et al.  Radiation-induced cardiovascular injury , 2008, Radiation and environmental biophysics.

[165]  C. Recklitis,et al.  Complementary and alternative therapy use in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study , 2008, Pediatric blood & cancer.

[166]  Mark F. Lutz,et al.  Monitoring of Anthracycline-Induced Cardiotoxicity , 2008, The Annals of pharmacotherapy.

[167]  M. Hudson,et al.  Emerging issues in smoking among adolescent and adult cancer survivors , 2007, Cancer.

[168]  G. Sutherland,et al.  Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[169]  S. Barlow,et al.  Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. , 2007, Pediatrics.

[170]  D. Friedman,et al.  Obesity and hypertension among children after treatment for acute lymphoblastic leukemia , 2007, Cancer.

[171]  S. Aggarwal,et al.  B‐type natriuretic peptide as a marker for cardiac dysfunction in anthracycline‐treated children , 2007, Pediatric blood & cancer.

[172]  M. Jarfelt,et al.  Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.

[173]  R. Napoli,et al.  Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure. , 2007, The Journal of clinical endocrinology and metabolism.

[174]  K. Hellmann.  Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[175]  S. Lipshultz,et al.  Anthracycline associated cardiotoxicity in survivors of childhood cancer , 2007, Heart.

[176]  R. Ross,et al.  Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. , 2007, The Journal of clinical endocrinology and metabolism.

[177]  F. Shamsa,et al.  High Blood Pressure Trends in Children and Adolescents in National Surveys, 1963 to 2002 , 2007, Circulation.

[178]  Chao-Po Lin,et al.  Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. , 2007, Cancer research.

[179]  J. Bryant,et al.  Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. , 2007, European journal of cancer.

[180]  E. Rosenkranz,et al.  Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting , 2007 .

[181]  T. Merchant,et al.  Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[182]  S. Rose,et al.  Long-term endocrine sequelae of childhood cancer , 2007, Current opinion in pediatrics.

[183]  L. Siu,et al.  Molecularly targeted oncology therapeutics and prolongation of the QT interval. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[184]  S. Lipsitz,et al.  Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[185]  T. Rowland,et al.  A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines , 2007, Pediatric blood & cancer.

[186]  L. Constine,et al.  Late effects of therapy for Hodgkin’s lymphoma , 2007, Current hematologic malignancy reports.

[187]  Monique W M Jaspers,et al.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. , 2007, JAMA.

[188]  L. Robison,et al.  Childhood cancer survivors, late effects, and a new model for understanding survivorship. , 2007, JAMA.

[189]  D. Reinhardt,et al.  Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML , 2007, Pediatric blood & cancer.

[190]  N. Carlsen,et al.  Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.

[191]  J. Ensor,et al.  Long-term complications of platinum-based chemotherapy in testicular cancer survivors , 2007, Medical oncology.

[192]  D. McDonald,et al.  Mechanisms of adverse effects of anti-VEGF therapy for cancer , 2007, British Journal of Cancer.

[193]  S. Blair,et al.  Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. , 2007, JAMA.

[194]  I. Papassotiriou,et al.  Early Indicators of Dysmetabolic Syndrome in Young Survivors of Acute Lymphoblastic Leukemia in Childhood as a Target for Preventing Disease , 2007, Journal of pediatric hematology/oncology.

[195]  H. Caron,et al.  Prevention of anthracycline-induced cardiotoxicity in children: the evidence. , 2007, European journal of cancer.

[196]  U. Walker,et al.  Role of mtDNA lesions in anthracycline cardiotoxicity , 2007, Cardiovascular Toxicology.

[197]  S. Lipshultz.  Heart failure in childhood cancer survivors , 2007, Nature Clinical Practice Oncology.

[198]  L. Gianni,et al.  Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes , 2007, Cardiovascular Toxicology.

[199]  S. Lipshultz,et al.  Anthracycline cardiotoxicity in long-term survivors of childhood cancer , 2007, Cardiovascular Toxicology.

[200]  Delia Outomuro,et al.  Adriamycin-induced myocardial toxicity: new solutions for an old problem? , 2007, International journal of cardiology.

[201]  Marc S Jacobson,et al.  Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. , 2007, Circulation.

[202]  J. Svensson,et al.  A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. , 2007, The Journal of clinical endocrinology and metabolism.

[203]  Y. Arbel,et al.  QT prolongation and Torsades de Pointes in patients previously treated with Anthracyclines , 2007, Anti-cancer drugs.

[204]  S. Pomeroy,et al.  Moyamoya following cranial irradiation for primary brain tumors in children , 2007, Neurology.

[205]  A. Hart,et al.  Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.

[206]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[207]  K. Emmons,et al.  Availability of smoking prevention and cessation services for childhood cancer survivors , 2007, Cancer Causes & Control.

[208]  L. Constine,et al.  Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[209]  A. Horwich,et al.  Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. , 2007, Journal of the National Cancer Institute.

[210]  L. Constine,et al.  Long-term effects of treatments for childhood cancers , 2007, Current opinion in pediatrics.

[211]  A. Alexandrov,et al.  Guidelines for Screening of Extracranial Carotid Artery Disease: A Statement for Healthcare Professionals from the Multidisciplinary Practice Guidelines Committee of the American Society of Neuroimaging; Cosponsored by the Society of Vascular and Interventional Neurology , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[212]  H. Caron,et al.  Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. , 2006, European journal of cancer.

[213]  H. Caron,et al.  Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. , 2006, European journal of cancer.

[214]  K. Steinbeck,et al.  Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. , 2006, The Journal of clinical endocrinology and metabolism.

[215]  T. Merchant,et al.  Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes. , 2006, International journal of radiation oncology, biology, physics.

[216]  S. Fosså,et al.  Components of the metabolic syndrome in long-term survivors of testicular cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[217]  Xin Huang,et al.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.

[218]  J. Vonk,et al.  Long-term cardiac follow-up in survivors of a malignant bone tumour. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[219]  K. Ness,et al.  Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia , 2006, Cancer.

[220]  W. Shi,et al.  Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. , 2006, The Journal of clinical endocrinology and metabolism.

[221]  T. Wallimann,et al.  New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. , 2006, Journal of molecular and cellular cardiology.

[222]  Robin L. Jones,et al.  Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs , 2006, Expert review of anticancer therapy.

[223]  S. Yusuf,et al.  Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.

[224]  Kevin C Oeffinger,et al.  Comprehensive long‐term follow‐up programs for pediatric cancer survivors , 2006, Cancer.

[225]  Brian Walters,et al.  Cardiotoxicity of the cancer therapeutic agent imatinib mesylate , 2006, Nature Medicine.

[226]  L. Fried,et al.  The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. , 2006, Journal of the American College of Cardiology.

[227]  L. Gianni,et al.  Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies , 2006, Journal of Pharmacology and Experimental Therapeutics.

[228]  A. Ng,et al.  Cardiac status predicts quality of life in Hodgkin's disease survivors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[229]  S. Lipshultz.  Exposure to anthracyclines during childhood causes cardiac injury. , 2006, Seminars in oncology.

[230]  J. Kirklin,et al.  Outcomes of Children Bridged to Heart Transplantation With Ventricular Assist Devices: A Multi-Institutional Study , 2006, Circulation.

[231]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[232]  K. Courneya,et al.  An Examination of Physical Activity Behaviors in a Sample of Adolescent Cancer Survivors , 2006, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[233]  P. Ridker,et al.  Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. , 2006, JAMA.

[234]  K. Flaherty,et al.  Mechanisms of hypertension associated with BAY 43-9006. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[235]  K. Ness,et al.  Physical performance limitations and participation restrictions among cancer survivors: a population-based study. , 2006, Annals of epidemiology.

[236]  A. Støylen,et al.  Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. , 2006, Journal of the American College of Cardiology.

[237]  T. Takken,et al.  Physical function and fitness in long-term survivors of childhood leukaemia , 2006, Pediatric rehabilitation.

[238]  S. Colan,et al.  The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity , 2006, Leukemia & lymphoma.

[239]  M. Pfreundschuh,et al.  NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity , 2005, Circulation.

[240]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[241]  S. Lipshultz,et al.  Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies , 2005, British journal of haematology.

[242]  S. Sallan,et al.  Wise up: Do not do it without protection! , 2005, Pediatric blood & cancer.

[243]  J. Rowland,et al.  Health behaviors of cancer survivors: examining opportunities for cancer control intervention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[244]  D. Moody,et al.  Vascular Damage after Fractionated Whole-Brain Irradiation in Rats , 2005, Radiation Research.

[245]  S. Hancock,et al.  Diastolic dysfunction after mediastinal irradiation. , 2005, American heart journal.

[246]  Q. Bashir,et al.  Cardiotoxicity of cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[247]  G. Dini,et al.  Exercise capacity in apparently healthy survivors of cancer , 2005, Archives of Disease in Childhood.

[248]  K. Emmons,et al.  Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[249]  Yan Liu,et al.  Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[250]  J. Twisk,et al.  Effects of 10 years of growth hormone (GH) replacement therapy in adult GH‐deficient men , 2005, Clinical endocrinology.

[251]  T. Wilsgaard,et al.  Blood pressure and body mass index in long-term survivors of testicular cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[252]  S. Rai,et al.  Adolescent survivors: A secondary analysis of a clinical trial targeting behavior change , 2005, Pediatric blood & cancer.

[253]  P. Raina,et al.  Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. , 2005, Evidence report/technology assessment.

[254]  S. Russell,et al.  Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. , 2005, The Annals of thoracic surgery.

[255]  S. Lipshultz,et al.  Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and prevention , 2005, Pediatric blood & cancer.

[256]  P. Thompson,et al.  Prevention of coronary artery disease in cancer patients , 2005, Pediatric blood & cancer.

[257]  S. Lipsitz,et al.  Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines , 2005, Pediatrics.

[258]  E. Coups,et al.  A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. , 2005, Preventive medicine.

[259]  E. Clipp,et al.  Survivors of childhood cancer and their guardians , 2005, Cancer.

[260]  F. V. van Leeuwen,et al.  Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. , 2005, Cancer treatment reviews.

[261]  S. Lipshultz,et al.  Exercise rehabilitation of pediatric patients with cardiovascular disease , 2005 .

[262]  K. Aytemir,et al.  Doxorubicin-induced second degree and complete atrioventricular block. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[263]  S. Lipsitz,et al.  Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[264]  J. Towbin,et al.  Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. , 2005, Journal of the American College of Cardiology.

[265]  N. Meydan,et al.  Ultrasound Tissue Characterization by Integrated Backscatter for Analyzing Fluorouracil Induced Myocardial Damage , 2005, Echocardiography.

[266]  L. F. Fajardo.  The pathology of ionizing radiation as defined by morphologic patterns* , 2005, Acta oncologica.

[267]  P. Morandi,et al.  Cardiac toxicity of high-dose chemotherapy , 2005, Bone Marrow Transplantation.

[268]  P. Libby,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. , 2004, Circulation.

[269]  D. Green,et al.  Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[270]  R. D. de Haan,et al.  Quality of life, self‐esteem and worries in young adult survivors of childhood cancer , 2004, Psycho-oncology.

[271]  J. Björk,et al.  Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. , 2004, The Journal of clinical endocrinology and metabolism.

[272]  G. Levitt,et al.  Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function , 2004, Heart.

[273]  M. Thelen,et al.  Anthrazyklin-induzierte Kardiotoxizität: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen , 2004 .

[274]  C. Canter,et al.  Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[275]  K. Emmons,et al.  Multiple risk behaviors among smokers in the childhood cancer survivors study cohort , 2004, Psycho-oncology.

[276]  L. Robison,et al.  Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[277]  S. Lipsitz,et al.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[278]  S. Lipsitz,et al.  The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. , 2004, The New England journal of medicine.

[279]  J. Svensson,et al.  Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[280]  Sonia Caprio,et al.  Obesity and the metabolic syndrome in children and adolescents. , 2004, The New England journal of medicine.

[281]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[282]  P. Merlet,et al.  Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy , 2004, British Journal of Cancer.

[283]  P. Chanson,et al.  Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. , 2004, The Journal of clinical endocrinology and metabolism.

[284]  K. Ohta,et al.  QT dispersion correlates with systolic rather than diastolic parameters in patients receiving anthracycline treatment. , 2004, Internal medicine.

[285]  B. Barlogie,et al.  Bradycardia during therapy for multiple myeloma with thalidomide. , 2004, The American journal of cardiology.

[286]  S. Lipsitz,et al.  A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses. , 2004, Pediatrics.

[287]  Weiling Zhao,et al.  Chronic oxidative stress and radiation‐induced late normal tissue injury: a review , 2004, International journal of radiation biology.

[288]  R. Packer,et al.  Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. , 2004, Neuro-oncology.

[289]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[290]  C. McMahon,et al.  Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[291]  D. Lai,et al.  Overweight, ethnicity, and the prevalence of hypertension in school-aged children. , 2004, Pediatrics.

[292]  S. Colan,et al.  Cardiovascular trials in long-term survivors of childhood cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[293]  J. Silber,et al.  Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[294]  C. Pepine,et al.  Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.

[295]  S. Dobrić,et al.  Amifostine protection against doxorubicin cardiotoxicity in rats , 2004, Anti-cancer drugs.

[296]  G. Levitt,et al.  Does anthracycline administration by infusion in children affect late cardiotoxicity? , 2004, British journal of haematology.

[297]  E. Perez,et al.  Clinical cardiac tolerability of trastuzumab. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[298]  G. Berry,et al.  Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies , 2004, Cancer investigation.

[299]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[300]  Jörg Haberstroh,et al.  Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy , 2003, Circulation.

[301]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[302]  S. Goldhaber,et al.  Trace element risk assessment: essentiality vs. toxicity. , 2003, Regulatory toxicology and pharmacology : RTP.

[303]  Paul Chen,et al.  Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. , 2003, Cancer research.

[304]  H. Bartelink,et al.  Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[305]  E. Ford.  C-Reactive Protein Concentration and Cardiovascular Disease Risk Factors in Children: Findings From the National Health and Nutrition Examination Survey 1999–2000 , 2003, Circulation.

[306]  H. Caron,et al.  Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[307]  S. Hancock,et al.  Asymptomatic cardiac disease following mediastinal irradiation. , 2003, Journal of the American College of Cardiology.

[308]  T. Safra.  Cardiac safety of liposomal anthracyclines. , 2003, The oncologist.

[309]  Takashi Okamoto,et al.  Sino-atrial block during anesthesia in a patient with breast cancer being treated with the anticancer drug epirubicin. , 2003, Anesthesia and analgesia.

[310]  L. Constine,et al.  Radiation-associated cardiovascular disease: manifestations and management. , 2003, Seminars in radiation oncology.

[311]  Daniel Levy,et al.  The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening , 2003, Annals of Internal Medicine.

[312]  N. Cheung,et al.  Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. , 2003, Medical and pediatric oncology.

[313]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[314]  G. Levitt,et al.  Late anthracycline cardiotoxicity after childhood cancer , 2003, Cancer.

[315]  E. Laurila,et al.  Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. , 2003, The Journal of clinical endocrinology and metabolism.

[316]  J. Gattuso,et al.  Intervention to reduce intentions to use tobacco among pediatric cancer survivors. , 2003, Journal of Clinical Oncology.

[317]  T. Fears,et al.  Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[318]  C. Yajnik,et al.  -to: Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595–601 , 2003, Diabetologia.

[319]  L. Robison,et al.  Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors , 2003, Cancer.

[320]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[321]  K. Kodama,et al.  Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors , 2003, International journal of radiation biology.

[322]  S. Lipsitz,et al.  Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[323]  J. Mackey,et al.  The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer. , 2002, The Journal of urology.

[324]  J. Quiles,et al.  Antioxidant nutrients and adriamycin toxicity. , 2002, Toxicology.

[325]  Richard V. Williams,et al.  Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[326]  W. Kamps,et al.  Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: a longitudinal study. , 2002, Medical and pediatric oncology.

[327]  A. Smit,et al.  The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. , 2002, Cancer treatment reviews.

[328]  M. Preece,et al.  Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study , 2002, The Lancet.

[329]  L. Robison,et al.  Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. , 2002, The Journal of clinical endocrinology and metabolism.

[330]  P. Voûte,et al.  Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[331]  D. Gaudet,et al.  Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia , 2002, Circulation.

[332]  J. Svensson,et al.  Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. , 2002, The Journal of clinical endocrinology and metabolism.

[333]  K. Emmons,et al.  Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[334]  S. Lipsitz,et al.  Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[335]  J. Warner,et al.  Body composition of long-term survivors of acute lymphoblastic leukaemia. , 2002, Medical and pediatric oncology.

[336]  C. Ardies.  Exercise, Cachexia, and Cancer Therapy: A Molecular Rationale , 2002, Nutrition and cancer.

[337]  C. Hudis,et al.  Cardiac dysfunction in the trastuzumab clinical trials experience. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[338]  R. Vasan,et al.  Alcohol Consumption and Risk for Congestive Heart Failure in the Framingham Heart Study , 2002, Annals of Internal Medicine.

[339]  M. Link,et al.  Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[340]  H. Thaler,et al.  PRESENCE OF PROLONGED DISPERSION OF QT INTERVALS IN LATE SURVIVORS OF CHILDHOOD ANTHRACYCLINE THERAPY , 2002, Pediatric hematology and oncology.

[341]  S. Lipshultz,et al.  Cardiomyopathy caused by antineoplastic therapies , 2001, Current treatment options in cardiovascular medicine.

[342]  D. Jacobs,et al.  Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. , 2001, The Journal of pediatrics.

[343]  B. Guy-grand,et al.  Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study , 2001, The Lancet.

[344]  V. Ferrans,et al.  The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity , 2001, Cancer Chemotherapy and Pharmacology.

[345]  M. Galderisi,et al.  Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood , 2001, Clinical cardiology.

[346]  M. Alpsten,et al.  A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. , 2001, The Journal of clinical endocrinology and metabolism.

[347]  M. Denke,et al.  Cardiovascular Risk Factors in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia , 2001, Journal of pediatric hematology/oncology.

[348]  J. Reilly,et al.  Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. , 2001, The Journal of clinical endocrinology and metabolism.

[349]  E Glattre,et al.  Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[350]  A. D. Cunningham,et al.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population , 2001, Heart.

[351]  J. Schulz-Menger,et al.  Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. , 2001, American heart journal.

[352]  F. Cetta,et al.  Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. , 2001, The American journal of cardiology.

[353]  D. Jacobs,et al.  Adiposity in childhood predicts obesity and insulin resistance in young adulthood. , 2001, The Journal of pediatrics.

[354]  D. Galuska,et al.  C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, The Journal of pediatrics.

[355]  N. Breslow,et al.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[356]  C. Canter,et al.  Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. , 2001, The Journal of pediatrics.

[357]  G. Batist,et al.  Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[358]  M. Goran.  Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. , 2001, The American journal of clinical nutrition.

[359]  E. Nakashima,et al.  Persistent subclinical inflammation among A-bomb survivors , 2001, International journal of radiation biology.

[360]  N. Labropoulos,et al.  A Prospective Study of the Effects of Irradiation on the Carotid Artery , 2000, The Laryngoscope.

[361]  M. Sontag,et al.  Late Effects of Ionizing Radiation on the Microvascular Networks in Normal Tissue , 2000, Radiation research.

[362]  J. Jørgensen,et al.  The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. , 2000, The Journal of clinical endocrinology and metabolism.

[363]  S. Müller-Weihrich,et al.  Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood , 2000, Cardiology in the Young.

[364]  J. Newell,et al.  Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia , 2000, International Journal of Obesity.

[365]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[366]  T. Spinks,et al.  Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. , 2000, The Journal of clinical endocrinology and metabolism.

[367]  J. Thijssen,et al.  Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. , 2000, Ultrasound in medicine & biology.

[368]  L. Caprino,et al.  Cisplatin triggers platelet activation. , 2000, Thrombosis research.

[369]  L. Robison,et al.  Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. , 2000, Medical and pediatric oncology.

[370]  W. Kamps,et al.  Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. , 2000, Medical and pediatric oncology.

[371]  M. Ranke,et al.  Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood , 2000, Hormone Research in Paediatrics.

[372]  Chulhyun Kim,et al.  Association between birth weight and insulin sensitivity in healthy young men in Korea: role of visceral adiposity. , 2000, Diabetes research and clinical practice.

[373]  G R Sutherland,et al.  Assessment of regional longitudinal myocardial strain rate derived from doppler myocardial imaging indexes in normal and infarcted myocardium. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[374]  N. Skakkebaek,et al.  Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. , 2000, The Journal of clinical endocrinology and metabolism.

[375]  P. Armstrong,et al.  Adverse effects of corticosteroids on the cardiovascular system. , 2000, The Canadian journal of cardiology.

[376]  E. Shpall,et al.  Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[377]  P. Czernichow,et al.  Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. , 2000, The Journal of clinical endocrinology and metabolism.

[378]  D. Strachan,et al.  C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. , 2000, Atherosclerosis.

[379]  Clive Osmond,et al.  Effects of Infant Birthweight and Maternal Body Mass Index in Pregnancy on Components of the Insulin Resistance Syndrome in China , 2000, Annals of Internal Medicine.

[380]  W. Wallace,et al.  OBESITY IN LEUKEMIA SURVIVORS: The Familial Contribution , 2000, Pediatric hematology and oncology.

[381]  C. Mølgaard,et al.  Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. , 1999, The Journal of clinical endocrinology and metabolism.

[382]  S. Nussey,et al.  Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index , 1999, Archives of disease in childhood.

[383]  P Colonna,et al.  Effects of acute myocardial ischemia on intramyocardial contraction heterogeneity: A study performed with ultrasound integrated backscatter during transesophageal atrial pacing. , 1999, Circulation.

[384]  D. Green,et al.  Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[385]  W. Hobbie,et al.  Testing the effects of a decision-making and risk-reduction program for cancer-surviving adolescents. , 1999, Oncology nursing forum.

[386]  T. Yokoyama,et al.  Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. , 1999, Circulation research.

[387]  J. Debus,et al.  Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. , 1999, Radiology.

[388]  V. Ferrans,et al.  Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[389]  S. Gidding,et al.  Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[390]  S. Colan,et al.  Doxorubicin-induced cardiomyopathy. , 1999, The New England journal of medicine.

[391]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[392]  B. Bülow,et al.  A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF‐I without significant deterioration in glucose tolerance , 1999, Clinical endocrinology.

[393]  Y. C. Chen,et al.  Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia , 1998, British journal of haematology.

[394]  P. Singal,et al.  Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.

[395]  M. Packer,et al.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.

[396]  W. Dietz,et al.  Obesity Evaluation and Treatment: Expert Committee Recommendations , 1998 .

[397]  T. Spinks,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients , 2022 .

[398]  S. Lipshultz,et al.  Epidemiology of anthracycline cardiotoxicity in children and adults. , 1998, Seminars in oncology.

[399]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[400]  P. Trumbo,et al.  Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. , 1998, Journal of the American Dietetic Association.

[401]  D. Johnston,et al.  Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH‐deficient adults , 1998, Clinical endocrinology.

[402]  J. Christiansen,et al.  Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. , 1998, Medical and pediatric oncology.

[403]  C. Rantzau,et al.  Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. , 1998, The Journal of clinical endocrinology and metabolism.

[404]  G. Rosner,et al.  Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation. , 1998, Radiation research.

[405]  J. Gorcsan,et al.  Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. , 1998, The American journal of cardiology.

[406]  C. Hennekens.  Risk factors for coronary heart disease in women. , 1998, Cardiology clinics.

[407]  S. Lipsitz,et al.  Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[408]  T. Robinson,et al.  Use of the body mass index (BMI) as a measure of overweight in children and adolescents. , 1998, The Journal of pediatrics.

[409]  M. Goran,et al.  Assessment of research-based body composition techniques in healthy elderly men and women using the 4-compartment model as a criterion method , 1998, International Journal of Obesity.

[410]  D B Allison,et al.  Body mass index as a measure of adiposity among children and adolescents: a validation study. , 1998, The Journal of pediatrics.

[411]  M. Bristow.  Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.

[412]  I. Goldenberg,et al.  Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. , 1997, The American journal of the medical sciences.

[413]  J. Krischer,et al.  Risk factors for early anthracycline clinical cardiotoxicity in children: the pediatric oncology group experience , 1997 .

[414]  S. Lipsitz,et al.  Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. , 1997, Circulation.

[415]  L. Ho,et al.  Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. , 1997 .

[416]  N. Skakkebaek,et al.  Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. , 1997, The Journal of clinical endocrinology and metabolism.

[417]  X. Thomas,et al.  Mitoxantrone in the treatment of acute myelogenous leukemia: a review. , 1997, Hematology and cell therapy.

[418]  L. Burke,et al.  Symptomatic Cardiotoxicity Associated with 5‐Fluorouracil , 1997, Pharmacotherapy.

[419]  T. Cole,et al.  Review: Measurement and long-term health risks of child and adolescent fatness , 1997, International Journal of Obesity.

[420]  R. Martino,et al.  A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism. , 1997, Cellular and molecular biology.

[421]  H. Lamb,et al.  Oral Idarubicin , 1997, Drugs & aging.

[422]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.

[423]  Ibrahim Özdoğru,et al.  Correction: Pregnancy-Related Thromboembolism , 1997, Annals of Internal Medicine.

[424]  M. Kimura,et al.  Influence of selenium deficiency on the acute cardiotoxicity of adriamycin in rats , 1997, Biological Trace Element Research.

[425]  J. Krischer,et al.  Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[426]  S. Sallan,et al.  Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. , 1997, Blood.

[427]  B. Perret,et al.  Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. , 1997, Biochimica et biophysica acta.

[428]  C. Bokemeyer,et al.  Evaluation of long-term toxicity after chemotherapy for testicular cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[429]  W. Tamborlane,et al.  Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children , 1996, Diabetologia.

[430]  J. Manson,et al.  Obesity and cardiovascular disease. , 1996, Current opinion in cardiology.

[431]  L. Vecchia.  Physiologic Dual Chamber Pacing in Radiation-lnduced Atrioventricular Block , 1996 .

[432]  M. Knip,et al.  Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[433]  W. Edwards,et al.  Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases , 1996 .

[434]  S. Tonstad,et al.  Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. , 1996, The Journal of pediatrics.

[435]  Hancock,et al.  Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. , 1996, Seminars in radiation oncology.

[436]  S. Ferrari,et al.  The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin. , 1996, Journal of chemotherapy.

[437]  J. Kongerud,et al.  Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. , 1996, Heart.

[438]  A. R. Marchese,et al.  Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. , 1996, Cardiovascular surgery.

[439]  L. Sjöström,et al.  Comparison of methods to estimate body fat in growth hormone deficient adults , 1996, Clinical endocrinology.

[440]  S. Arslanian,et al.  Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? , 1996, The Journal of clinical endocrinology and metabolism.

[441]  A S Leon,et al.  Physical activity, nutrition, and chronic disease. , 1996, Medicine and science in sports and exercise.

[442]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[443]  S. Lipshultz.  Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[444]  S. Srinivasan,et al.  Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. , 1996, Metabolism: clinical and experimental.

[445]  L. Packer,et al.  Vitamin E: beyond antioxidant function. , 1995, The American journal of clinical nutrition.

[446]  E. Schuetz,et al.  Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. , 1995, The Journal of pharmacology and experimental therapeutics.

[447]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[448]  M. Deitel,et al.  Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.

[449]  A. Meadows.  Curing cancer in children: minimizing price, maximizing value. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[450]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[451]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[452]  F. Lampert,et al.  Severe cardiotoxicity of high-dose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in a 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor). , 1995, Oncology.

[453]  A. Ogilvy-Stuart,et al.  High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. , 1995, The Journal of pediatrics.

[454]  E J Orav,et al.  Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.

[455]  P. Steinherz,et al.  Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. , 1995, Medical and pediatric oncology.

[456]  L. Kalish,et al.  Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. , 1995, The cancer journal from Scientific American.

[457]  M. Siimes,et al.  Cardiopulmonary evaluation of exercise tolerance after chest irradiation and anticancer chemotherapy in children and adolescents. , 1995, Pediatrics.

[458]  V. Katch,et al.  Relationship between insulin resistance and abnormal lipid profile in obese adolescents. , 1995, The Journal of pediatrics.

[459]  M. Korth,et al.  Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium. , 1995, Circulation research.

[460]  J. R. Stewart,et al.  Radiation injury to the heart. , 1995, International journal of radiation oncology, biology, physics.

[461]  C. Sklar,et al.  Chronic neuroendocrinological sequelae of radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[462]  Cheng Jiang,et al.  Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. , 1995, Carcinogenesis.

[463]  R. Pardini,et al.  Enhancement of the antineoplastic effect of mitomycin C by dietary fat. , 1994, Cancer research.

[464]  R. Dorr,et al.  Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro. , 1994, Chemico-biological interactions.

[465]  D. O'Neal,et al.  The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. , 1994, The Journal of clinical endocrinology and metabolism.

[466]  L. Tesoriere,et al.  Vitamin A preserves the cytotoxic activity of adriamycin while counteracting its peroxidative effects in human leukemic cells in vitro. , 1994, Biochemistry and molecular biology international.

[467]  J. Reilly,et al.  Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. , 1994, Archives of disease in childhood.

[468]  K. Schärer,et al.  Usefulness of Bioelectric Impedance and Skinfold Measurements in Predicting Fat-Free Mass Derived from Total Body Potassium in Children , 1994, Pediatric Research.

[469]  S. Colan,et al.  Monitoring for anthracycline cardiotoxicity. , 1994, Pediatrics.

[470]  M. Verheij,et al.  Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. , 1994, Radiation research.

[471]  J. Manson,et al.  Body weight and mortality. A 27-year follow-up of middle-aged men. , 1993, JAMA.

[472]  D. Wysowski,et al.  Risk of leukemia after treatment with pituitary growth hormone. , 1993, JAMA.

[473]  B. Bengtsson,et al.  Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. , 1993, Metabolism: clinical and experimental.

[474]  S L Hancock,et al.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.

[475]  E. Ravussin,et al.  Estimating body composition of young children by using bioelectrical resistance. , 1993, Journal of applied physiology.

[476]  M. Horimoto,et al.  Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. , 1993, American heart journal.

[477]  H. Toshima,et al.  A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. , 1993, Biochemical and biophysical research communications.

[478]  E. Thiel,et al.  Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease , 1993, British journal of haematology.

[479]  M. Rousseau,et al.  Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. , 1993, Circulation.

[480]  S. Sallan,et al.  Cardiovascular abnormalities in long-term survivors of childhood malignancy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[481]  J. Silber,et al.  Cardiac dysfunction following spinal irradiation during childhood. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[482]  R. Demicheli,et al.  Drugs ten years later: epirubicin. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[483]  F. Gaita,et al.  Associated cardiac lesions in patients with radiation-induced complete heart block. , 1993, International journal of cardiology.

[484]  R. Brown,et al.  Survival of cancer patients on therapy with coenzyme Q10. , 1993, Biochemical and biophysical research communications.

[485]  A. Neims,et al.  4‐Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells , 1993, Journal of cellular biochemistry.

[486]  L. Steinherz,et al.  Sick sinus syndrome in a teenager treated with idarubicin. , 1993, Journal of cardiothoracic and vascular anesthesia.

[487]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[488]  D. Levy,et al.  Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). , 1992, The American journal of cardiology.

[489]  H. Caron,et al.  Cancer in Children: Clinical Management , 1992 .

[490]  C. Hales,et al.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.

[491]  J. Kupersmith,et al.  Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. , 1992, Journal of the American College of Cardiology.

[492]  J. Silber,et al.  Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. , 1992, The American journal of cardiology.

[493]  A. Bartolucci,et al.  A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[494]  R. Schwartz,et al.  Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. , 1992, Pediatrics.

[495]  J. G. Miller,et al.  Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. , 1992, Journal of the American College of Cardiology.

[496]  J. Arnaud,et al.  Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats , 1992, Basic Research in Cardiology.

[497]  Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.

[498]  M. Shamoto,et al.  Ascorbic acid and adriamycin toxicity. , 1991, The American journal of clinical nutrition.

[499]  V. Martí,et al.  Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. , 1991, Chest.

[500]  P. Steinherz,et al.  Cardiac toxicity 4 to 20 years after completing anthracycline therapy. , 1991, JAMA.

[501]  E K Rowinsky,et al.  Cardiac disturbances during the administration of taxol. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[502]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[503]  E. Cook,et al.  Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[504]  S. Colan,et al.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[505]  J. Doroshow.  Doxorubicin-induced cardiac toxicity. , 1991, The New England journal of medicine.

[506]  J. Alexander,et al.  Radiation-associated valvular disease. , 1991, Chest.

[507]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[508]  B. Griffith,et al.  Heart transplantation in patients with malignant disease. , 1990, The Journal of heart transplantation.

[509]  T. Landberg,et al.  Original article: Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease , 1990 .

[510]  R. Brasseur,et al.  Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. , 1990, Biophysical chemistry.

[511]  M. Yacoub,et al.  CARDIAC TRANSPLANTATION FOR DOXORUBICIN‐INDUCED CARDIOMYOPATHY IN ACUTE MYELOID LEUKAEMIA , 1990, British journal of haematology.

[512]  P. Hekali,et al.  Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. , 1990, Bone marrow transplantation.

[513]  D. Ettinger,et al.  Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. , 1989 .

[514]  S. Sallan,et al.  Hypertension in long-term survivors of childhood renal cancers. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[515]  R. Willson,et al.  Vitamin A and glutathione-mediated free radical damage: competing reactions with polyunsaturated fatty acids and vitamin C. , 1989, Biochemical and biophysical research communications.

[516]  Y. S. Lee,et al.  Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. , 1989, Journal of molecular and cellular cardiology.

[517]  F. Bonetti,et al.  Heart transplantation in a child with doxorubicin-induced cardiomyopathy. , 1988, The New England journal of medicine.

[518]  J. Verweij,et al.  A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C , 1988, Medical oncology and tumor pharmacotherapy.

[519]  M. Ogura,et al.  The occurrence of acute lymphoblastic leukemia shortly after the cessation of human growth hormone therapy. , 1988, Japanese journal of clinical oncology.

[520]  D. Pennington,et al.  Bridging to cardiac transplantation with pulsatile ventricular assist devices. , 1988, The Annals of thoracic surgery.

[521]  J. Lintermans,et al.  Orthotopic heart transplantation eleven years after left pneumonectomy. , 1988, The Journal of heart transplantation.

[522]  J. Ward,et al.  Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug. , 1988, Cancer research.

[523]  U. Sasaki,et al.  Occurrence of acute lymphoblastic leukemia in a boy treated with growth hormone for growth retardation after irradiation to the brain tumor. , 1988, Japanese journal of clinical oncology.

[524]  W. C. Sheldon,et al.  Clinical and angiographic features of coronary artery disease after chest irradiation. , 1987, The American journal of cardiology.

[525]  K. Dohi,et al.  The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. , 1987, Surgery.

[526]  M. Fiorotto,et al.  Total body electrical conductivity measurements: effects of body composition and geometry. , 1987, The American journal of physiology.

[527]  M. Goldberg,et al.  Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. , 1986, Blood.

[528]  J. Hainsworth,et al.  Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. , 1986, Annals of internal medicine.

[529]  S. Marsoni,et al.  Amsacrine-associated cardiotoxicity: an analysis of 82 cases. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[530]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[531]  K. Ingold,et al.  Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. , 1985, Biochimica et biophysica acta.

[532]  B. Issell,et al.  Amsacrine (AMSA)--a clinical review. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[533]  L. F. Fajardo,et al.  Radiation-induced heart disease: an update. , 1984 .

[534]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[535]  S. Colan,et al.  Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. , 1984, Journal of the American College of Cardiology.

[536]  J. Glick,et al.  Phase I trials of WR-2721 and cis-platinum. , 1984, International journal of radiation oncology, biology, physics.

[537]  G. Gaedicke,et al.  Therapy of acute lymphocytic leukemia in childhood with intermediate dose methotrexate and CNS irradiation , 1983, Blut.

[538]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[539]  M. Hafermann,et al.  Coronary artery disease following mediastinal radiation therapy. , 1983, The Journal of thoracic and cardiovascular surgery.

[540]  F. Haschke,et al.  Body composition of reference children from birth to age 10 years. , 1982, The American journal of clinical nutrition.

[541]  S. Wallace,et al.  Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.

[542]  E. W. Bradley,et al.  Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. , 1981, International journal of radiation oncology, biology, physics.

[543]  R. D. Couch,et al.  Sudden cardiac death following adriamycin therapy , 1981, Cancer.

[544]  J. Gottdiener,et al.  Cardiotoxicity associated with high-dose cyclophosphamide therapy. , 1981, Archives of internal medicine.

[545]  S. I. Cohen,et al.  Radiotherapy as a cause of complete atrioventricular block in Hodgkin's disease. An electrophysiological-pathological correlation. , 1981, Archives of internal medicine.

[546]  W. Roberts,et al.  Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. , 1981, The American journal of medicine.

[547]  H. Pinedo,et al.  Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit. , 1980, Cancer research.

[548]  Y. M. Wang,et al.  Effect of vitamin E against adriamycin-induced toxicity in rabbits. , 1980, Cancer research.

[549]  V. Ferrans,et al.  Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. , 1980, The American journal of pathology.

[550]  H. von Melchner,et al.  Adriamycin cardiotoxicity: a survey of 1273 patients. , 1979, Cancer treatment reports.

[551]  A. B. Combs,et al.  Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[552]  K. Folkers,et al.  Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. , 1978, Cancer treatment reports.

[553]  Van Vleet Jf,et al.  Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits. , 1978 .

[554]  J. Mason,et al.  Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. , 1978, Annals of internal medicine.

[555]  I. Ifrim,et al.  Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.

[556]  L. F. Fajardo.  Radiation-induced coronary artery disease. , 1977, Chest.

[557]  R. Carmel,et al.  Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications , 1976, Cancer.

[558]  T. Kishi,et al.  Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes. , 1976, Cancer treatment reports.

[559]  S. Sternberg,et al.  The cardiotoxicity of adriamycin and daunomycin in children , 1976, Cancer.

[560]  R. Byhardt,et al.  Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease , 1975, Cancer.

[561]  C. G. Blomqvist,et al.  Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10. , 1974, Biochemical and biophysical research communications.

[562]  M. At,et al.  Late effects of cancer treatment: methods and techniques for detection. , 1974 .

[563]  A. Tappel,et al.  The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. , 1966, The Journal of biological chemistry.

[564]  H. Lofland,et al.  Ionizing radiation, atherosclerosis, and lipid metabolism in pigeons. , 1965, Radiation research.

[565]  G. Amromin,et al.  THE SYNERGISM OF X-IRRADIATION AND CHOLESTEROL-FAT FEEDING ON THE DEVELOPMENT OF CORONARY ARTERY LESIONS. , 1964, Journal of atherosclerosis research.

[566]  S. Lindsay,et al.  Aortic Arteriosclerosis in the Dog After Localized Aortic X‐lrradiation , 1962, Circulation research.

[567]  J. Stockman.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort , 2011 .

[568]  G. Recondo,et al.  Antineoplastic chemotherapy induced QTc prolongation. , 2010, Current drug safety.

[569]  Tongyu Lin,et al.  Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin’s lymphoma: single center, 15-year experience , 2010, International journal of hematology.

[570]  K. Emmons,et al.  Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[571]  R Wakeford,et al.  A Systematic Review of Epidemiological Associations between Low and Moderate Doses of Ionizing Radiation and Late Cardiovascular Effects, and Their Possible Mechanisms , 2008, Radiation research.

[572]  K. Trott,et al.  Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? , 2007, International journal of radiation oncology, biology, physics.

[573]  A. Favier,et al.  Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin , 2007, Biological Trace Element Research.

[574]  Margarita Pérez,et al.  Effects of an intrahospital exercise program intervention for children with leukemia. , 2007, Medicine and science in sports and exercise.

[575]  S. Lipshultz,et al.  Cardiotoxicity of Cancer Chemotherapy , 2005, Paediatric drugs.

[576]  W. Stöhr,et al.  Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS) , 2005, Journal of Cancer Research and Clinical Oncology.

[577]  S. Treves,et al.  Cardiac toxicity of mediastinal radiotherapy : Which are the critical structures? , 2005 .

[578]  J. Toumbourou,et al.  Health-risk behaviours among adolescent survivors of childhood cancer. , 2005, Pediatric blood & cancer.

[579]  G. Prindull,et al.  The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia , 2004, European Journal of Pediatrics.

[580]  C. Osmond,et al.  Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth , 2004, Diabetologia.

[581]  A. La Cava,et al.  Unraveling the multiple roles of leptin in inflammation and autoimmunity , 2004, Journal of Molecular Medicine.

[582]  M. Vassilomanolakis,et al.  Ifosfamide cardiotoxicity in humans , 2004, Cancer Chemotherapy and Pharmacology.

[583]  H. Caron,et al.  Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review. , 2004, European journal of cancer.

[584]  Steven E Lipshultz,et al.  Radiation-associated cardiovascular disease. , 2003, Critical reviews in oncology/hematology.

[585]  M. Lorenzato,et al.  Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment. , 2003, Anticancer research.

[586]  B. Fervers,et al.  Evidence-based paediatric oncology , 2002 .

[587]  Lyndsay Harris,et al.  Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma , 2002, Cancer.

[588]  R. Murray,et al.  GH-deficient survivors of childhood cancer: GH replacement during adult life. , 2002, The Journal of clinical endocrinology and metabolism.

[589]  Mario J. Garcia,et al.  Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility , 2002, Circulation.

[590]  S. Chen,et al.  Clinical spectrum of restrictive cardiomyopathy in children. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[591]  N. Mayr,et al.  Late effects in children treated with radiation therapy for Wilms' tumor. , 2000, International journal of radiation oncology, biology, physics.

[592]  V. Ferrans,et al.  Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats , 2000, Cancer Chemotherapy and Pharmacology.

[593]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[594]  C. Takahashi,et al.  Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures. , 1999, Teratogenesis, carcinogenesis, and mutagenesis.

[595]  P. Kaufmann,et al.  Cardiac risk after mediastinal irradiation for Hodgkin's disease. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[596]  S. Lipshultz,et al.  Anthracycline-induced cardiotoxicity in children and young adults. , 1998, Critical reviews in oncology/hematology.

[597]  S. Colan,et al.  Late cardiotoxicity following anthracycline therapy for childhood cancer , 1998 .

[598]  G. Reaven.  Insulin Resistance and Human Disease: A Short History , 1998, Journal of basic and clinical physiology and pharmacology.

[599]  S. Lipshultz,et al.  Cardiovascular disease in long-term survivors of pediatric Hodgkin's disease , 1998 .

[600]  G. Levitt,et al.  Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[601]  J. Strong,et al.  Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[602]  P. Rubin,et al.  Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. , 1996, International journal of radiation oncology, biology, physics.

[603]  M. Siimes,et al.  Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. , 1996, European journal of cancer.

[604]  J. Cunningham,et al.  The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. , 1995, The Journal of clinical endocrinology and metabolism.

[605]  W. Oster,et al.  Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences. , 1995, European journal of cancer.

[606]  R. Jenni,et al.  Cardiac lesions after mediastinal irradiation for Hodgkin's disease. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[607]  D. Iarussi,et al.  Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. , 1994, Molecular aspects of medicine.

[608]  F. Ognibene,et al.  High-Dose Ifosfamide Is Associated with Severe, Reversible Cardiac Dysfunction , 1993, Annals of Internal Medicine.

[609]  N. Krinsky.  Actions of carotenoids in biological systems. , 1993, Annual review of nutrition.

[610]  H. Joensuu.  Myocardial infarction after irradiation in Hodgkin's disease: a review. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[611]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[612]  J. Himes.  Anthropometric assessment of nutritional status , 1991 .

[613]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[614]  S. Lipshultz,et al.  Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. , 1990, The Journal of pediatrics.

[615]  D. Urbanová.  The role of endomyocardial biopsy in the diagnosis and treatment of heart disease. , 1989, Acta Universitatis Carolinae. Medica.

[616]  J. G. Miller,et al.  Ultrasound integrated backscatter tissue characterization of remote myocardial infarction in human subjects. , 1989, Journal of the American College of Cardiology.

[617]  Y. Kaneko,et al.  Possible association of human growth hormone treatment with an occurrence of acute myeloblastic leukemia with an inversion of chromosome 3 in a child of pituitary dwarfism. , 1988, Medical and pediatric oncology.

[618]  L. F. Fajardo,et al.  Vascular lesions following radiation. , 1988, Pathology annual.

[619]  W. Roberts,et al.  Coronary heart disease after mediastinal irradiation for Hodgkin's disease. , 1976, The American journal of medicine.

[620]  L. F. Fajardo,et al.  Radiation-induced heart disease. Clinical and experimental aspects. , 1971, Radiologic clinics of North America.

[621]  L. F. Fajardo,et al.  Morphology of radiation-induced heart disease. , 1968, Archives of pathology.

[622]  E. Antman,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .